Lp-PLA2-IN-4 是脂蛋白相关磷脂酶 A2 (Lp-PLA2) 的有效抑制剂。Lp-PLA2 以前称为血小板活化因子乙酰水解酶 (PAF-AH)，是一种参与脂蛋白脂质或磷脂水解的磷脂酶 A2。Lp-PLA2-IN-4 具有研究与 Lp-PLA2 活性相关的疾病的潜力，例如动脉粥样硬化、阿尔茨海默病 (信息摘自专利 WO2021228159A1，化合物 38)。

Lp-PLA2-IN-4 is a potent inhibitor of lipoprotein-associated phospholipase A2 ( Lp-PLA2 ). Lp-PLA2 previously known as platelet- activating factor acetylhydrolase (PAF-AH), is a phospholipase A2 enzyme involved in hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2-IN-4 has the potential for the research of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease (extracted from patent WO2021228159A1, compound 38) [1].

2738877-91-1

C23H18F5N3O4

495.4

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years